Innate Pharma (IPHA) Net Margin (2020 - 2024)
Innate Pharma posted quarterly Net Margin of 461.93% for Q4 2024, down 34735.0% year-on-year from N/an in Q1 2024, and down 54.69% on a QoQ basis from 298.61% in Q2 2024.
Innate Pharma (IPHA) has 5 years of Net Margin data on file, last reported at 461.93% in Q4 2024.
- For the quarter ending Q4 2024, Net Margin fell 34735.0% year-over-year to 461.93%; the trailing twelve-month figure through Dec 2024 stood at 130.49% (down 6507.0% YoY), and the FY2025 full-year result was 778.76%, up 82266.0% from the prior year.
- Net Margin for Q4 2024 stood at 461.93%, down from 298.61% in the prior quarter.
- Across five years, Net Margin topped out at 1.61% in Q2 2023 and bottomed at 464.6% in Q4 2021.
- The 5-year median for Net Margin is 206.6% (2024), against an average of 227.85%.
- The widest annual swing landed in 2022, when Net Margin jumped 37071 bps; it then slumped 34735 bps in 2024.
- A 5-year view of Net Margin shows it stood at 390.23% in 2020, then retreated by 19 bps to 464.6% in 2021, then soared by 80 bps to 93.89% in 2022, then retreated by 22 bps to 114.59% in 2023, then sank by 303 bps to 461.93% in 2024.
- The last three Net Margin figures came in at 461.93% (Q4 2024), 298.61% (Q2 2024), and 114.59% (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 0.82% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 34.53% |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 20.17% |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 17.65% |
| 10 | Innate Pharma | 199.64 Mn | 199.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -461.93% |
| Jun 30, 2024 | -298.61% |
| Dec 31, 2023 | -114.59% |
| Jun 30, 2023 | 1.61% |
| Dec 31, 2022 | -93.89% |
| Jun 30, 2022 | -0.54% |
| Dec 31, 2021 | -464.60% |
| Dec 31, 2020 | -390.23% |